Therapy with basal insulin and GLP-1 RA should be discontinued prior to initiation of Xultophy® 100/3.61
Starting and titrating patients on Xultophy® 100/3.6
Xultophy® 100/3.6 has 2 starting doses
![Man standing and smiling](/content/dam/novonordisk/xultophy10036pro/Images/XUL_patient_charles.png)
In patients naïve to basal insulin or a GLP-1 RA
10 UNITS
10 units=10 units of insulin degludec and 0.36 mg liraglutide1
![Man standing and smiling](/content/dam/novonordisk/xultophy10036pro/Images/XUL_patient_charles.png)
In patients converting from basal insulin or a GLP-1 RA
16 UNITS
16 units=16 units of insulin degludec and 0.58 mg liraglutide1
![Woman smiling](/content/dam/novonordisk/xultophy10036pro/Images/XUL_patient_amanda.png)
![primary_msg](/content/dam/novonordisk/xultophy10036pro/tracking-pixels/primary_msg.gif)
![Check mark](/content/dam/novonordisk/xultophy10036pro/Images/checkmark@2x.png)
Dose once daily at the same time each day with or without food1
![Check mark](/content/dam/novonordisk/xultophy10036pro/Images/checkmark@2x.png)
No waiting to inject when removed from the refrigerator1
GLP-1 RA=glucagon-like peptide-1 receptor agonist.
Looking for coverage? More of your patients may be covered than you think.
![](/content/dam/novonordisk/xultophy10036pro/Images/XUL_70%@2x.png)
Looking for coverage? More of your patients may be covered than you think.
As basal insulin dose is dialed, GLP-1 RA automatically adjusts
Delivers a fixed-ratio combination in increments of 1 unit1
The dose counter on the Xultophy® 100/3.6 pen displays numbers for the even units and displays lines for the odd units.
Titrate every 3-4 days based on FPG1
- Maximum dose: 50 units=50 units of insulin degludec and 1.8 mg liraglutide1
- In DUAL V, patients adjusted their dose on Monday and Thursday of each week2